U.S. Senator Bill Cassidy, M.D., Chairman of the Senate Health, Education, Labor, and Pensions Committee, along with Senators Steve Daines, James Lankford, Cindy Hyde-Smith, and Lindsey Graham, announced on Mar. 25 an investigation into chemical abortion drug manufacturers' compliance with U.S. Food and Drug Administration safeguards for marketing their products. The senators also called on the FDA to address illegal online sales of unapproved chemical abortion drugs.
The issue centers on concerns about public health and safety as more chemical abortion drugs are sold online without oversight or prescriptions. The senators argue that this trend increases risks for women and undermines federal regulations designed to protect consumers.
“Chemical abortion drug makers profit off killing innocent children while putting mothers’ lives at risk,” said Cassidy. “These manufacturers and websites have facilitated the explosion in online sales of these harmful drugs without regard for women’s health and safety while opening the door for coercion and abuse. FDA should act within its existing authorities to curb this abuse and immediately reinstate safeguards such as the in-person dispensing requirement.”
Other senators echoed similar concerns about safety protocols being weakened or removed in recent years. “There is substantial real-world evidence that shows chemical abortion is harmful to women, and it’s past time that we put commonsense safeguards in place,” said Daines. Lankford added: “The FDA must enforce the law, hold manufacturers accountable and crack down on illegal distribution.” Hyde-Smith noted reports that more than one in ten women who take mifepristone experience serious adverse events.
Cassidy previously led a hearing focused on these issues with Louisiana Attorney General Liz Murrill present. He has also filed an amicus brief supporting a return to stricter dispensing requirements for mifepristone.
Advocacy group leaders expressed support for the Senate's actions through several statements included in the announcement.
The Senate Health, Education, Labor, and Pensions Committee plays a central role legislating public health policies—including oversight of agencies like the FDA—and influences federal regulations affecting health across the United States according to its official website. Cassidy served as chair during this period according to committee records.
Looking ahead, supporters say they expect continued pressure from Congress for stricter enforcement by both regulators and manufacturers regarding chemical abortion drugs.
